|
1
|
Dallol A, Krex D, Hesson L, Eng C, Maher
ER and Latif F: Frequent epigenetic inactivation of the SLIT2 gene
in gliomas. Oncogene. 22:4611–4616. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grauer OM, Wesseling P and Adema GJ:
Immunotherapy of diffuse gliomas: biological background, current
status and future development. Brain Pathol. 19:674–693. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dontula R, Dinasarapu A, Chetty C, et al:
MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9
Signaling. Genes Cancer. 4:285–296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Long JM and Lahiri DK: Advances in
microRNA experimental approaches to study physiological regulation
of gene products implicated in CNS disorders. Exp Neurol.
235:402–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park S and James CD: ECop
(EGFR-coamplified and overexpressed protein), a novel protein,
regulates NF-kappaB transcriptional activity and associated
apoptotic response in an IkappaBalpha-dependent manner. Oncogene.
24:2495–2502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu B, Hsu PK, Karayiorgou M and Gogos JA:
MicroRNA dysregulation in neuropsychiatric disorders and cognitive
dysfunction. Neurobiol Dis. 46:291–301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, et al: Targeting of the Bmi-1 oncogene/stem cell
renewal factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Silber J, Lim DA, Petritsch C, et al:
MiR-124 and miR-137 inhibit proliferation of glioblastoma
multiforme cells and induce differentiation of brain tumor stem
cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rao SA, Santosh V and Somasundaram K:
Genome-wide expression profiling identifies deregulated miRNAs in
malignant astrocytoma. Mod Pathol. 23:1404–1417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song L, Huang Q, Chen K, et al: miR-218
inhibits the invasive ability of glioma cells by direct
downregulation of IKK-β. Biochem Biophys Res Commun. 402:135–140.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia H, Yan Y, Hu M, et al: MiR-218
sensitizes glioma cells to apoptosis and inhibits tumorigenicity by
regulating ECOP-mediated suppression of NF-κB activity. Neuro
Oncol. 15:413–422. 2013. View Article : Google Scholar :
|
|
14
|
Liu Y, Yan W, Zhang W, et al: MiR-218
reverses high invasiveness of glioblastoma cells by targeting the
oncogenic transcription factor LEF1. Oncol Rep. 28:1013–1021.
2012.PubMed/NCBI
|
|
15
|
Zhang JM, Sun CY, Yu SZ, et al:
Relationship between miR-218 and CDK6 expression and their
biological impact on glioma cell proliferation and apoptosis.
Zhonghua Bing Li Xue Za Zhi. 40:454–459. 2011.(In Chinese).
PubMed/NCBI
|
|
16
|
Tie J, Pan Y, Zhao L, et al: MiR-218
inhibits invasion and metastasis of gastric cancer by targeting the
Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alajez NM, Lenarduzzi M, Ito E, et al:
MiR-218 suppresses nasopharyngeal cancer progression through
downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res.
71:2381–2391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stupp R, Mason WP, van den Bent MJ, et al;
European Organisation for Research and Treatment of Cancer Brain
Tumor and Radiotherapy Groups; National Cancer Institute of Canada
Clinical Trials Group. Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Furnari FB, Fenton T, Bachoo RM, et al:
Malignant astrocytic glioma: genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yiin JJ, Hu B, Jarzynka MJ, et al: Slit2
inhibits glioma cell invasion in the brain by suppression of Cdc42
activity. Neuro Oncol. 11:779–789. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martinez I, Gardiner AS, Board KF, et al:
Human papillomavirus type 16 reduces the expression of microRNA-218
in cervical carcinoma cells. Oncogene. 27:2575–2582. 2008.
View Article : Google Scholar :
|
|
22
|
Petrocca F, Visone R, Onelli MR, et al:
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest
and apoptosisin gastric cancer. Cancer Cell. 13:272–286. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu Y, Li WL, Fu L, et al: Slit2/Robo1
signaling in glioma migration and invasion. Neurosci Bull.
26:474–478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mertsch S, Schmitz N, Jeibmann A, et al:
Slit2 involvement in glioma cell migration is mediated by Robo1
receptor. J Neurooncol. 87:1–7. 2008. View Article : Google Scholar
|
|
26
|
Bader AG, Brown D and Winkler M: The
promise of microRNA replacement therapy. Cancer Res. 70:7027–7030.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roth P, Wischhusen J, Happold C, et al: A
specific miRNA signature in the peripheral blood of glioblastoma
patients. J Neurochem. 118:449–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
